FindTrial
Sign In

Effects of antioxidant supplementation Coenzyme Q10 in women with Metabolic Syndrome and liver fat

Effects of Coenzyme Q10 suplementation in women with Metabolic Syndrome and hepatic steatosis: double-blind controlled randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-26cq7n
Enrollment
Unknown
Registered
2018-06-21
Start date
2018-02-12
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome and Hepatic steatosis

Interventions

This study is a randomized double-blind controlled clinical trial that will be performed at the Hospital das Clínicas of the Medical School of Ribeirão Preto, University of São Paulo (HCFMRP-USP), wit
Drug
D27.505.519.217

Sponsors

Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Lead Sponsor
Universidade de São Paulo
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: women; age between 20 and 55 years; sedentary; not menopausal; Body mass index less than 40 kg / m2; carrier of Metabolic Syndrome; with hepatic steatosis.

Exclusion criteria

Exclusion criteria: current gestation / lactation; smoking; alcoholism; inflammatory rheumatologic, intestinal and hepatic diseases; confirmed cancer; polycystic ovary syndrome; confirmed diabetes mellitus (type 1 or 2); refractory arterial hypertension; thyroid disease; use of Ginkgo biloba and statins; Supplementation with vitamin E or CoQ10 in the last three months

Design outcomes

Primary

MeasureTime frame
Metabolic Syndrome: evaluation of abdominal circumference, blood pressure, HDL-cholesterol, triglycerides and fasting glycemia. Pre and post intervention evaluation through blood tests, anthropometrics and gauging.—

Secondary

MeasureTime frame
Hepatic steatosis: To quantify the degree of liver fat through magnetic resonance before and after intervention.—

Countries

Brazil

Contacts

Public ContactAlceu;Daniela Jordão Júnior;Casagrande

Faculdade de Medicina de Ribeirão Preto/FMRP/USP;Universidade de São Paulo

alceu@fmrp.usp.br;casagrande.dani@hotmail.com+55 (16) 3315-4000;+55 (14) 997640075

Outcome results

None listed

Source: REBEC (via WHO ICTRP)